Information  X 
Enter a valid email address
  Print          More announcements

Tuesday 05 July, 2022

UBS AG (EPT)

Form 8.5 (EPT/RI) - Mediclinic International plc

RNS Number : 3728R
UBS AG (EPT)
05 July 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the Code)

 

1.  KEY INFORMATION

 

(a) Name of exempt principal trader:

  UBS Investment Bank, London

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

  Use a separate form for each offeror/offeree

  Mediclinic International plc

(c) Name of the party to the offer with which exempt principal trader is connected:

  Mediclinic International plc

(d) Date dealing undertaken:

  04 July 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

  If it is a cash offer or possible cash offer, state "N/A"

NO

 

2.  DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)  Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Buy

 

247522

4.66718  GBP

4.54366  GBP

10p ordinary

Sell

 

135051

4.66599  GBP

4.54366  GBP

 

(b)  Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

 

Long

213

4.61742  GBP

10p ordinary

CFD

 

Long

1116

4.596377  GBP

10p ordinary

CFD

 

Long

5319

4.651513  GBP

10p ordinary

CFD

 

Long

1579

4.654025  GBP

10p ordinary

CFD

 

Long

163

4.600074  GBP

10p ordinary

CFD

 

Long

2103

4.61732322  GBP

10p ordinary

CFD

 

Long

38

4.618  GBP

10p ordinary

CFD

 

Long

5185

91.22171649  ZAR

10p ordinary

CFD

 

Long

11950

90.92686778  ZAR

10p ordinary

CFD

 

Long

1009

91.1909811694747  ZAR

10p ordinary

CFD

 

Long

845

91.2263668639053  ZAR

10p ordinary

CFD

 

Long

435

4.63993  GBP

10p ordinary

CFD

 

Long

278

4.603155  GBP

10p ordinary

CFD

 

Long

220

4.639907  GBP

10p ordinary

CFD

 

Short

21

4.552091  GBP

10p ordinary

CFD

 

Short

7523

4.66  GBP

10p ordinary

CFD

 

Short

11950

90.92686778  ZAR

10p ordinary

CFD

 

Short

5185

91.22171649  ZAR

10p ordinary

CFD

 

Short

1854

91.20710895  ZAR

10p ordinary

CFD

 

Short

10572

4.647587  GBP

10p ordinary

CFD

 

Short

4807

4.64743083003953  GBP

10p ordinary

CFD

 

Short

26589

4.63934826  GBP

10p ordinary

CFD

 

Short

4724

4.57700889077053  GBP

10p ordinary

CFD

 

Short

244

4.63819672131148  GBP

10p ordinary

CFD

 

Short

10981

4.627027  GBP

10p ordinary

CFD

 

Short

9501

4.659027  GBP

10p ordinary

CFD

 

Short

4907

4.617023  GBP

10p ordinary

CFD

 

Short

2213

4.648229  GBP

10p ordinary

CFD

 

Short

1741

4.64232  GBP

10p ordinary

CFD

 

Short

26221

4.61353  GBP

10p ordinary

CFD

 

Short

53

4.544091  GBP

 

(c)  Stock-settled derivative transactions (including options)

 

(i)  Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit









 

(ii)  Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d)  Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

3.  OTHER INFORMATION

 

(a)  Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none "

 

None

 

 

(b)  Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

05 July 2022

Contact name:

Richard Howard

Telephone number:

+44 (0)207 568 9128

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERRAMLTMTIMMBT

a d v e r t i s e m e n t